ExpreS2ion Biotech Holding AB Net Asset Quality Index
ExpreS2ion Biotech Holding AB net asset quality index. ExpreS2ion Biotech Holding AB (EXPRS2) has a Net Asset Quality Index of 52.4% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr50.40 Million minus total liabilities of Skr23.98 Million yields net assets of Skr26.42 Million. A higher index indicates a stronger, lower-leverage balance sheet. See EXPRS2 total equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of ExpreS2ion Biotech Holding AB (2013–2025)
Net asset quality index of ExpreS2ion Biotech Holding AB from 2013 to 2025. This chart shows how ExpreS2ion Biotech Holding AB's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the index stands at 52.4%, representing net assets of Skr26.42 Million against total assets of Skr50.40 Million SEK. Check EXPRS2 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
ExpreS2ion Biotech Holding AB Net Asset Quality Index by Year (2013–2025)
ExpreS2ion Biotech Holding AB net asset quality index by year from 2013 to 2025. The table below presents the year-by-year Net Asset Quality Index for ExpreS2ion Biotech Holding AB from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ExpreS2ion Biotech Holding AB (EXPRS2) total market value.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 54.8% | Skr35.69 Million | Skr65.11 Million | Skr29.42 Million | ▼ -6.8 pp |
| 2024 | 61.6% | Skr64.42 Million | Skr104.53 Million | Skr40.11 Million | ▼ -21.4 pp |
| 2023 | 83.1% | Skr65.36 Million | Skr78.69 Million | Skr13.33 Million | ▲ +7.8 pp |
| 2022 | 75.2% | Skr103.33 Million | Skr137.36 Million | Skr34.04 Million | ▼ -17.1 pp |
| 2021 | 92.4% | Skr140.35 Million | Skr151.96 Million | Skr11.61 Million | ▲ +12.8 pp |
| 2020 | 79.5% | Skr94.55 Million | Skr118.86 Million | Skr24.31 Million | ▲ +85.3 pp |
| 2019 | -5.8% | Skr-1.08 Million | Skr18.71 Million | Skr19.79 Million | ▼ -45.4 pp |
| 2018 | 39.6% | Skr8.30 Million | Skr20.95 Million | Skr12.65 Million | ▲ +0.5 pp |
| 2017 | 39.1% | Skr6.74 Million | Skr17.23 Million | Skr10.50 Million | ▼ -13.2 pp |
| 2016 | 52.3% | Skr12.88 Million | Skr24.61 Million | Skr11.73 Million | ▲ +199.1 pp |
| 2015 | -146.8% | Skr-6.01 Million | Skr4.09 Million | Skr10.10 Million | ▼ -189.6 pp |
| 2014 | 42.8% | Skr2.35 Million | Skr5.48 Million | Skr3.13 Million | ▼ -4.2 pp |
| 2013 | 47.0% | Skr1.93 Million | Skr4.11 Million | Skr2.18 Million | — |